Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways
Veysel Özgür Barış, Adnan Berk Dinçsoy, Esra Gedikli, Selim Zırh, Sevda Müftüoğlu, Ayşen Erdem
Topics & Concepts
EmpagliflozinMedicineCardiotoxicityEMPADoxorubicinKaryorrhexisPharmacologyInternal medicineChemotherapyEndocrinologyDiabetes mellitusType 2 diabetesApoptosisChemistryProgrammed cell deathMineralogyBiochemistryElectron microprobeChemotherapy-induced cardiotoxicity and mitigationMetabolism, Diabetes, and CancerDiabetes Treatment and Management